ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oncology Based Preclinical CRO Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-39H8946
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oncology Based Preclinical CRO Market Size Status and Forecast 2022
BUY CHAPTERS

Global Oncology Based Preclinical CRO Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-39H8946
Report
June 2025
Pages:141
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Crown Bioscience
Charles River
ICON
Eurofins Scientific
Taconic Biosciences
Covance
Evotec AG
The Jackson Laboratory
MI Bioresearch
Champion Oncology
WuXi AppTec
Xentech
Living Tumor Laboratory

Oncology Based Preclinical CRO Market Size

In 2024, the global market size of Oncology Based Preclinical CRO was estimated to be worth US$ 480 million and is forecast to reach approximately US$ 1075 million by 2031 with a CAGR of 12.4% during the forecast period 2025-2031.

Oncology Based Preclinical CRO Market

Oncology Based Preclinical CRO Market

Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible.
The industry"s leading producers are Crown Bioscience, Charles River and ICON, with revenues of 18.32 percent, 13.86 percent and 9.13 percent in 2019.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oncology Based Preclinical CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Based Preclinical CRO.
The Oncology Based Preclinical CRO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncology Based Preclinical CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology Based Preclinical CRO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Oncology Based Preclinical CRO Market Report

Report Metric Details
Report Name Oncology Based Preclinical CRO Market
Forecasted market size in 2031 approximately US$ 1075 million
CAGR 12.4%
Forecasted years 2025 - 2031
Segment by Type
  • Blood Cancer
  • Solid Tumors
  • Others
Segment by Application
  • In Vitro
  • In Vivo
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Crown Bioscience, Charles River, ICON, Eurofins Scientific, Taconic Biosciences, Covance, EVOTEC, The Jackson Laboratory, MI Bioresearch, Champion Oncology, Wuxi AppTec., Xentech, Living Tumor Laboratory
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Oncology Based Preclinical CRO in global and regional level.
  • Chapter 3: Detailed analysis of Oncology Based Preclinical CRO company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oncology Based Preclinical CRO revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Oncology Based Preclinical CRO Market size in 2031?

Ans: The Oncology Based Preclinical CRO Market size in 2031 will be approximately US$ 1075 million.

Who are the main players in the Oncology Based Preclinical CRO Market report?

Ans: The main players in the Oncology Based Preclinical CRO Market are Crown Bioscience, Charles River, ICON, Eurofins Scientific, Taconic Biosciences, Covance, EVOTEC, The Jackson Laboratory, MI Bioresearch, Champion Oncology, Wuxi AppTec., Xentech, Living Tumor Laboratory

What are the Application segmentation covered in the Oncology Based Preclinical CRO Market report?

Ans: The Applications covered in the Oncology Based Preclinical CRO Market report are In Vitro, In Vivo

What are the Type segmentation covered in the Oncology Based Preclinical CRO Market report?

Ans: The Types covered in the Oncology Based Preclinical CRO Market report are Blood Cancer, Solid Tumors, Others

1 Study Coverage
1.1 Oncology Based Preclinical CRO Product Introduction
1.2 Market by Type
1.2.1 Global Oncology Based Preclinical CRO Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Blood Cancer
1.2.3 Solid Tumors
1.2.4 Others
1.3 Market by Application
1.3.1 Global Oncology Based Preclinical CRO Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 In Vitro
1.3.3 In Vivo
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Oncology Based Preclinical CRO Market Size Estimates and Forecasts
2.2 Oncology Based Preclinical CRO Market Size by Region: 2024 Versus 2031
2.2.1 Global Oncology Based Preclinical CRO Revenue by Region: 2020-2025
2.2.2 Global Oncology Based Preclinical CRO Revenue Forecast by Region (2026-2031)
2.2.3 Global Oncology Based Preclinical CRO Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Oncology Based Preclinical CRO Revenue by Type (2020-2031)
3.1.2 Global Oncology Based Preclinical CRO Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Oncology Based Preclinical CRO Revenue by Application (2020-2031)
3.2.2 Global Oncology Based Preclinical CRO Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Blood Cancer of Oncology Based Preclinical CRO Revenue Market Share by Application
3.3.2 Solid Tumors of Oncology Based Preclinical CRO Revenue Market Share by Application
3.3.3 Others of Oncology Based Preclinical CRO Revenue Market Share by Application
4 Global Oncology Based Preclinical CRO by Company
4.1 Global Oncology Based Preclinical CRO Revenue by Company (2020-2025)
4.2 Global Oncology Based Preclinical CRO Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Oncology Based Preclinical CRO Companies around the World: Ranking by Revenue
4.3.2 Global Oncology Based Preclinical CRO Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Oncology Based Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Oncology Based Preclinical CRO Companies Headquarters & Product Type
4.4.1 Global Oncology Based Preclinical CRO Companies Headquarters
4.4.2 Date of International Companies Enter into Oncology Based Preclinical CRO Market
4.4.3 Global Oncology Based Preclinical CRO Companies Product & Service
4.4.4 Blood Cancer Revenue Market Share of Oncology Based Preclinical CRO by Company
4.4.5 Solid Tumors Revenue Market Share of Oncology Based Preclinical CRO by Company
4.4.6 Others Revenue Market Share of Oncology Based Preclinical CRO by Company
4.5 Global Oncology Based Preclinical CRO Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Crown Bioscience
5.1.1 Crown Bioscience Corporation Information
5.1.2 Crown Bioscience Description, Business Overview
5.1.3 Crown Bioscience Oncology Based Preclinical CRO Products Offered
5.1.4 Crown Bioscience Oncology Based Preclinical CRO Revenue and Gross Margin (2020-2025)
5.1.5 Crown Bioscience Oncology Based Preclinical CRO Revenue by Product in 2024
5.1.6 Crown Bioscience Oncology Based Preclinical CRO Revenue by Application in 2024
5.1.7 Crown Bioscience Oncology Based Preclinical CRO Revenue by Geographic Area in 2024
5.1.8 Crown Bioscience Recent Developments
5.2 Charles River
5.2.1 Charles River Corporation Information
5.2.2 Charles River Description, Business Overview
5.2.3 Charles River Oncology Based Preclinical CRO Products Offered
5.2.4 Charles River Oncology Based Preclinical CRO Revenue and Gross Margin (2020-2025)
5.2.5 Charles River Oncology Based Preclinical CRO Revenue by Product in 2024
5.2.6 Charles River Oncology Based Preclinical CRO Revenue by Application in 2024
5.2.7 Charles River Oncology Based Preclinical CRO Revenue by Geographic Area in 2024
5.2.8 Charles River Recent Developments
5.3 ICON
5.3.1 ICON Corporation Information
5.3.2 ICON Description, Business Overview
5.3.3 ICON Oncology Based Preclinical CRO Products Offered
5.3.4 ICON Oncology Based Preclinical CRO Revenue and Gross Margin (2020-2025)
5.3.5 ICON Oncology Based Preclinical CRO Revenue by Product in 2024
5.3.6 ICON Oncology Based Preclinical CRO Revenue by Application in 2024
5.3.7 ICON Oncology Based Preclinical CRO Revenue by Geographic Area in 2024
5.3.8 ICON Recent Developments
5.4 Eurofins Scientific
5.4.1 Eurofins Scientific Corporation Information
5.4.2 Eurofins Scientific Description, Business Overview
5.4.3 Eurofins Scientific Oncology Based Preclinical CRO Products Offered
5.4.4 Eurofins Scientific Oncology Based Preclinical CRO Revenue and Gross Margin (2020-2025)
5.4.5 Eurofins Scientific Oncology Based Preclinical CRO Revenue by Product in 2024
5.4.6 Eurofins Scientific Oncology Based Preclinical CRO Revenue by Application in 2024
5.4.7 Eurofins Scientific Oncology Based Preclinical CRO Revenue by Geographic Area in 2024
5.4.8 Eurofins Scientific Recent Developments
5.5 Taconic Biosciences
5.5.1 Taconic Biosciences Corporation Information
5.5.2 Taconic Biosciences Description, Business Overview
5.5.3 Taconic Biosciences Oncology Based Preclinical CRO Products Offered
5.5.4 Taconic Biosciences Oncology Based Preclinical CRO Revenue and Gross Margin (2020-2025)
5.5.5 Taconic Biosciences Oncology Based Preclinical CRO Revenue by Product in 2024
5.5.6 Taconic Biosciences Oncology Based Preclinical CRO Revenue by Application in 2024
5.5.7 Taconic Biosciences Oncology Based Preclinical CRO Revenue by Geographic Area in 2024
5.5.8 Taconic Biosciences Recent Developments
5.6 Covance
5.6.1 Covance Corporation Information
5.6.2 Covance Description, Business Overview
5.6.3 Covance Oncology Based Preclinical CRO Products Offered
5.6.4 Covance Oncology Based Preclinical CRO Revenue and Gross Margin (2020-2025)
5.6.5 Covance Oncology Based Preclinical CRO Revenue by Product in 2024
5.6.6 Covance Oncology Based Preclinical CRO Revenue by Application in 2024
5.6.7 Covance Oncology Based Preclinical CRO Revenue by Geographic Area in 2024
5.6.8 Covance Recent Developments
5.7 EVOTEC
5.7.1 EVOTEC Corporation Information
5.7.2 EVOTEC Description, Business Overview
5.7.3 EVOTEC Oncology Based Preclinical CRO Products Offered
5.7.4 EVOTEC Oncology Based Preclinical CRO Revenue and Gross Margin (2020-2025)
5.7.5 EVOTEC Oncology Based Preclinical CRO Revenue by Product in 2024
5.7.6 EVOTEC Oncology Based Preclinical CRO Revenue by Application in 2024
5.7.7 EVOTEC Oncology Based Preclinical CRO Revenue by Geographic Area in 2024
5.7.8 EVOTEC Recent Developments
5.8 The Jackson Laboratory
5.8.1 The Jackson Laboratory Corporation Information
5.8.2 The Jackson Laboratory Description, Business Overview
5.8.3 The Jackson Laboratory Oncology Based Preclinical CRO Products Offered
5.8.4 The Jackson Laboratory Oncology Based Preclinical CRO Revenue and Gross Margin (2020-2025)
5.8.5 The Jackson Laboratory Oncology Based Preclinical CRO Revenue by Product in 2024
5.8.6 The Jackson Laboratory Oncology Based Preclinical CRO Revenue by Application in 2024
5.8.7 The Jackson Laboratory Oncology Based Preclinical CRO Revenue by Geographic Area in 2024
5.8.8 The Jackson Laboratory Recent Developments
5.9 MI Bioresearch
5.9.1 MI Bioresearch Corporation Information
5.9.2 MI Bioresearch Description, Business Overview
5.9.3 MI Bioresearch Oncology Based Preclinical CRO Products Offered
5.9.4 MI Bioresearch Oncology Based Preclinical CRO Revenue and Gross Margin (2020-2025)
5.9.5 MI Bioresearch Oncology Based Preclinical CRO Revenue by Product in 2024
5.9.6 MI Bioresearch Oncology Based Preclinical CRO Revenue by Application in 2024
5.9.7 MI Bioresearch Oncology Based Preclinical CRO Revenue by Geographic Area in 2024
5.9.8 MI Bioresearch Recent Developments
5.10 Champion Oncology
5.10.1 Champion Oncology Corporation Information
5.10.2 Champion Oncology Description, Business Overview
5.10.3 Champion Oncology Oncology Based Preclinical CRO Products Offered
5.10.4 Champion Oncology Oncology Based Preclinical CRO Revenue and Gross Margin (2020-2025)
5.10.5 Champion Oncology Oncology Based Preclinical CRO Revenue by Product in 2024
5.10.6 Champion Oncology Oncology Based Preclinical CRO Revenue by Application in 2024
5.10.7 Champion Oncology Oncology Based Preclinical CRO Revenue by Geographic Area in 2024
5.10.8 Champion Oncology Recent Developments
5.11 Wuxi AppTec.
5.11.1 Wuxi AppTec. Corporation Information
5.11.2 Wuxi AppTec. Description, Business Overview
5.11.3 Wuxi AppTec. Oncology Based Preclinical CRO Products Offered
5.11.4 Wuxi AppTec. Oncology Based Preclinical CRO Revenue and Gross Margin (2020-2025)
5.11.5 Wuxi AppTec. Oncology Based Preclinical CRO Revenue by Product in 2024
5.11.6 Wuxi AppTec. Oncology Based Preclinical CRO Revenue by Application in 2024
5.11.7 Wuxi AppTec. Oncology Based Preclinical CRO Revenue by Geographic Area in 2024
5.11.8 Wuxi AppTec. Recent Developments
5.12 Xentech
5.12.1 Xentech Corporation Information
5.12.2 Xentech Description, Business Overview
5.12.3 Xentech Oncology Based Preclinical CRO Products Offered
5.12.4 Xentech Oncology Based Preclinical CRO Revenue and Gross Margin (2020-2025)
5.12.5 Xentech Oncology Based Preclinical CRO Revenue by Product in 2024
5.12.6 Xentech Oncology Based Preclinical CRO Revenue by Application in 2024
5.12.7 Xentech Oncology Based Preclinical CRO Revenue by Geographic Area in 2024
5.12.8 Xentech Recent Developments
5.13 Living Tumor Laboratory
5.13.1 Living Tumor Laboratory Corporation Information
5.13.2 Living Tumor Laboratory Description, Business Overview
5.13.3 Living Tumor Laboratory Oncology Based Preclinical CRO Products Offered
5.13.4 Living Tumor Laboratory Oncology Based Preclinical CRO Revenue and Gross Margin (2020-2025)
5.13.5 Living Tumor Laboratory Oncology Based Preclinical CRO Revenue by Product in 2024
5.13.6 Living Tumor Laboratory Oncology Based Preclinical CRO Revenue by Application in 2024
5.13.7 Living Tumor Laboratory Oncology Based Preclinical CRO Revenue by Geographic Area in 2024
5.13.8 Living Tumor Laboratory Recent Developments
6 North America
6.1 North America Oncology Based Preclinical CRO Market Size YoY Growth 2020-2031
6.2 North America Oncology Based Preclinical CRO Market Facts & Figures by Country (2020-2031)
6.3 North America Oncology Based Preclinical CRO Revenue by Type (2020-2025)
6.4 North America Oncology Based Preclinical CRO Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Oncology Based Preclinical CRO Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Oncology Based Preclinical CRO Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Oncology Based Preclinical CRO Revenue by Type (2020-2025)
7.4 Asia-Pacific Oncology Based Preclinical CRO Revenue by Application (2020-2025)
8 Europe
8.1 Europe Oncology Based Preclinical CRO Market Size YoY Growth 2020-2031
8.2 Europe Oncology Based Preclinical CRO Market Facts & Figures by Country (2020-2031)
8.3 Europe Oncology Based Preclinical CRO Revenue by Type (2020-2025)
8.4 Europe Oncology Based Preclinical CRO Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Oncology Based Preclinical CRO Market Size YoY Growth 2020-2031
9.2 Latin America Oncology Based Preclinical CRO Market Facts & Figures by Country (2020-2031)
9.3 Latin America Oncology Based Preclinical CRO Revenue by Type (2020-2025)
9.4 Latin America Oncology Based Preclinical CRO Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Oncology Based Preclinical CRO Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Oncology Based Preclinical CRO Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Oncology Based Preclinical CRO Revenue by Type (2020-2025)
10.4 Middle East and Africa Oncology Based Preclinical CRO Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Oncology Based Preclinical CRO Supply Chain Analysis
11.2 Oncology Based Preclinical CRO Key Raw Materials and Upstream Suppliers
11.3 Oncology Based Preclinical CRO Clients Analysis
11.4 Oncology Based Preclinical CRO Sales Channel and Sales Model Analysis
11.4.1 Oncology Based Preclinical CRO Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Oncology Based Preclinical CRO Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Oncology Based Preclinical CRO Distributors
12 Oncology Based Preclinical CRO Market Dynamics
12.1 Oncology Based Preclinical CRO Industry Trends
12.2 Oncology Based Preclinical CRO Market Drivers
12.3 Oncology Based Preclinical CRO Market Challenges
12.4 Oncology Based Preclinical CRO Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Crown Bioscience
Charles River
ICON
Eurofins Scientific
Taconic Biosciences
Covance
Evotec AG
The Jackson Laboratory
MI Bioresearch
Champion Oncology
WuXi AppTec
Xentech
Living Tumor Laboratory
List of Tables
 Table 1. Global Oncology Based Preclinical CRO Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Oncology Based Preclinical CRO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Oncology Based Preclinical CRO Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Oncology Based Preclinical CRO Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Oncology Based Preclinical CRO Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Oncology Based Preclinical CRO Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Oncology Based Preclinical CRO Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Oncology Based Preclinical CRO Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Oncology Based Preclinical CRO Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Oncology Based Preclinical CRO Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Oncology Based Preclinical CRO Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Oncology Based Preclinical CRO Players by Revenue (US$ Million) in 2024
 Table 13. Global Oncology Based Preclinical CRO Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Oncology Based Preclinical CRO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Based Preclinical CRO as of 2024)
 Table 15. Global Oncology Based Preclinical CRO Companies Headquarters
 Table 16. Date of International Companies Enter into Oncology Based Preclinical CRO Market
 Table 17. Global Oncology Based Preclinical CRO Companies Product & Service
 Table 18. Global Oncology Based Preclinical CRO Mergers & Acquisitions, Expansion Plans
 Table 19. Crown Bioscience Corporation Information
 Table 20. Crown Bioscience Description and Business Overview
 Table 21. Crown Bioscience Oncology Based Preclinical CRO Product
 Table 22. Crown Bioscience Oncology Based Preclinical CRO Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Crown Bioscience Revenue Proportion of Oncology Based Preclinical CRO by Product in 2024
 Table 24. Crown Bioscience Revenue Proportion of Oncology Based Preclinical CRO by Application in 2024
 Table 25. Crown Bioscience Revenue Proportion of Oncology Based Preclinical CRO by Geographic Area in 2024
 Table 26. Crown Bioscience Recent Developments
 Table 27. Charles River Corporation Information
 Table 28. Charles River Description and Business Overview
 Table 29. Charles River Oncology Based Preclinical CRO Product
 Table 30. Charles River Oncology Based Preclinical CRO Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. Charles River Revenue Proportion of Oncology Based Preclinical CRO by Product in 2024
 Table 32. Charles River Revenue Proportion of Oncology Based Preclinical CRO by Application in 2024
 Table 33. Charles River Revenue Proportion of Oncology Based Preclinical CRO by Geographic Area in 2024
 Table 34. Charles River Recent Developments
 Table 35. ICON Corporation Information
 Table 36. ICON Description and Business Overview
 Table 37. ICON Oncology Based Preclinical CRO Product
 Table 38. ICON Oncology Based Preclinical CRO Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. ICON Revenue Proportion of Oncology Based Preclinical CRO by Product in 2024
 Table 40. ICON Revenue Proportion of Oncology Based Preclinical CRO by Application in 2024
 Table 41. ICON Revenue Proportion of Oncology Based Preclinical CRO by Geographic Area in 2024
 Table 42. ICON Recent Developments
 Table 43. Eurofins Scientific Corporation Information
 Table 44. Eurofins Scientific Description and Business Overview
 Table 45. Eurofins Scientific Oncology Based Preclinical CRO Product
 Table 46. Eurofins Scientific Oncology Based Preclinical CRO Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Eurofins Scientific Revenue Proportion of Oncology Based Preclinical CRO by Product in 2024
 Table 48. Eurofins Scientific Revenue Proportion of Oncology Based Preclinical CRO by Application in 2024
 Table 49. Eurofins Scientific Revenue Proportion of Oncology Based Preclinical CRO by Geographic Area in 2024
 Table 50. Eurofins Scientific Recent Developments
 Table 51. Taconic Biosciences Corporation Information
 Table 52. Taconic Biosciences Description and Business Overview
 Table 53. Taconic Biosciences Oncology Based Preclinical CRO Product
 Table 54. Taconic Biosciences Oncology Based Preclinical CRO Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. Taconic Biosciences Revenue Proportion of Oncology Based Preclinical CRO by Product in 2024
 Table 56. Taconic Biosciences Revenue Proportion of Oncology Based Preclinical CRO by Application in 2024
 Table 57. Taconic Biosciences Revenue Proportion of Oncology Based Preclinical CRO by Geographic Area in 2024
 Table 58. Taconic Biosciences Recent Developments
 Table 59. Covance Corporation Information
 Table 60. Covance Description and Business Overview
 Table 61. Covance Oncology Based Preclinical CRO Product
 Table 62. Covance Oncology Based Preclinical CRO Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. Covance Revenue Proportion of Oncology Based Preclinical CRO by Product in 2024
 Table 64. Covance Revenue Proportion of Oncology Based Preclinical CRO by Application in 2024
 Table 65. Covance Revenue Proportion of Oncology Based Preclinical CRO by Geographic Area in 2024
 Table 66. Covance Recent Developments
 Table 67. EVOTEC Corporation Information
 Table 68. EVOTEC Description and Business Overview
 Table 69. EVOTEC Oncology Based Preclinical CRO Product
 Table 70. EVOTEC Oncology Based Preclinical CRO Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. EVOTEC Revenue Proportion of Oncology Based Preclinical CRO by Product in 2024
 Table 72. EVOTEC Revenue Proportion of Oncology Based Preclinical CRO by Application in 2024
 Table 73. EVOTEC Revenue Proportion of Oncology Based Preclinical CRO by Geographic Area in 2024
 Table 74. EVOTEC Recent Developments
 Table 75. The Jackson Laboratory Corporation Information
 Table 76. The Jackson Laboratory Description and Business Overview
 Table 77. The Jackson Laboratory Oncology Based Preclinical CRO Product
 Table 78. The Jackson Laboratory Oncology Based Preclinical CRO Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. The Jackson Laboratory Revenue Proportion of Oncology Based Preclinical CRO by Product in 2024
 Table 80. The Jackson Laboratory Revenue Proportion of Oncology Based Preclinical CRO by Application in 2024
 Table 81. The Jackson Laboratory Revenue Proportion of Oncology Based Preclinical CRO by Geographic Area in 2024
 Table 82. The Jackson Laboratory Recent Developments
 Table 83. MI Bioresearch Corporation Information
 Table 84. MI Bioresearch Description and Business Overview
 Table 85. MI Bioresearch Oncology Based Preclinical CRO Product
 Table 86. MI Bioresearch Oncology Based Preclinical CRO Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. MI Bioresearch Revenue Proportion of Oncology Based Preclinical CRO by Product in 2024
 Table 88. MI Bioresearch Revenue Proportion of Oncology Based Preclinical CRO by Application in 2024
 Table 89. MI Bioresearch Revenue Proportion of Oncology Based Preclinical CRO by Geographic Area in 2024
 Table 90. MI Bioresearch Recent Developments
 Table 91. Champion Oncology Corporation Information
 Table 92. Champion Oncology Description and Business Overview
 Table 93. Champion Oncology Oncology Based Preclinical CRO Product
 Table 94. Champion Oncology Oncology Based Preclinical CRO Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 95. Champion Oncology Revenue Proportion of Oncology Based Preclinical CRO by Product in 2024
 Table 96. Champion Oncology Revenue Proportion of Oncology Based Preclinical CRO by Application in 2024
 Table 97. Champion Oncology Revenue Proportion of Oncology Based Preclinical CRO by Geographic Area in 2024
 Table 98. Champion Oncology Recent Developments
 Table 99. Wuxi AppTec. Corporation Information
 Table 100. Wuxi AppTec. Description and Business Overview
 Table 101. Wuxi AppTec. Oncology Based Preclinical CRO Product
 Table 102. Wuxi AppTec. Oncology Based Preclinical CRO Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Wuxi AppTec. Revenue Proportion of Oncology Based Preclinical CRO by Product in 2024
 Table 104. Wuxi AppTec. Revenue Proportion of Oncology Based Preclinical CRO by Application in 2024
 Table 105. Wuxi AppTec. Revenue Proportion of Oncology Based Preclinical CRO by Geographic Area in 2024
 Table 106. Wuxi AppTec. Recent Developments
 Table 107. Xentech Corporation Information
 Table 108. Xentech Description and Business Overview
 Table 109. Xentech Oncology Based Preclinical CRO Product
 Table 110. Xentech Oncology Based Preclinical CRO Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 111. Xentech Revenue Proportion of Oncology Based Preclinical CRO by Product in 2024
 Table 112. Xentech Revenue Proportion of Oncology Based Preclinical CRO by Application in 2024
 Table 113. Xentech Revenue Proportion of Oncology Based Preclinical CRO by Geographic Area in 2024
 Table 114. Xentech Recent Developments
 Table 115. Living Tumor Laboratory Corporation Information
 Table 116. Living Tumor Laboratory Description and Business Overview
 Table 117. Living Tumor Laboratory Oncology Based Preclinical CRO Product
 Table 118. Living Tumor Laboratory Oncology Based Preclinical CRO Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 119. Living Tumor Laboratory Revenue Proportion of Oncology Based Preclinical CRO by Product in 2024
 Table 120. Living Tumor Laboratory Revenue Proportion of Oncology Based Preclinical CRO by Application in 2024
 Table 121. Living Tumor Laboratory Revenue Proportion of Oncology Based Preclinical CRO by Geographic Area in 2024
 Table 122. Living Tumor Laboratory Recent Developments
 Table 123. North America Oncology Based Preclinical CRO Revenue by Country (2020-2025) & (US$ Million)
 Table 124. North America Oncology Based Preclinical CRO Revenue by Country (2026-2031) & (US$ Million)
 Table 125. North America Oncology Based Preclinical CRO Revenue by Type (2020-2025) & (US$ Million)
 Table 126. North America Oncology Based Preclinical CRO Revenue by Application (2020-2025) & (US$ Million)
 Table 127. Asia-Pacific Oncology Based Preclinical CRO Revenue by Region (2020-2025) & (US$ Million)
 Table 128. Asia-Pacific Oncology Based Preclinical CRO Revenue by Region (2026-2031) & (US$ Million)
 Table 129. Asia-Pacific Oncology Based Preclinical CRO Revenue by Type (2020-2025) & (US$ Million)
 Table 130. Asia-Pacific Oncology Based Preclinical CRO Revenue by Application (2020-2025) & (US$ Million)
 Table 131. Europe Oncology Based Preclinical CRO Revenue by Country (2020-2025) & (US$ Million)
 Table 132. Europe Oncology Based Preclinical CRO Revenue by Country (2026-2031) & (US$ Million)
 Table 133. Europe Oncology Based Preclinical CRO Revenue by Type (2020-2025) & (US$ Million)
 Table 134. Europe Oncology Based Preclinical CRO Revenue by Application (2020-2025) & (US$ Million)
 Table 135. Latin America Oncology Based Preclinical CRO Revenue by Country (2020-2025) & (US$ Million)
 Table 136. Latin America Oncology Based Preclinical CRO Revenue by Country (2026-2031) & (US$ Million)
 Table 137. Latin America Oncology Based Preclinical CRO Revenue by Type (2020-2025) & (US$ Million)
 Table 138. Latin America Oncology Based Preclinical CRO Revenue by Application (2020-2025) & (US$ Million)
 Table 139. Middle East and Africa Oncology Based Preclinical CRO Revenue by Country (2020-2025) & (US$ Million)
 Table 140. Middle East and Africa Oncology Based Preclinical CRO Revenue by Country (2026-2031) & (US$ Million)
 Table 141. Middle East and Africa Oncology Based Preclinical CRO Revenue by Type (2020-2025) & (US$ Million)
 Table 142. Middle East and Africa Oncology Based Preclinical CRO Revenue by Application (2020-2025) & (US$ Million)
 Table 143. Oncology Based Preclinical CRO Key Raw Materials, Industry Status and Trend
 Table 144. Oncology Based Preclinical CRO Key Raw Materials and Upstream Suppliers
 Table 145. Oncology Based Preclinical CRO Clients Status and Trend
 Table 146. Oncology Based Preclinical CRO Typical Clients
 Table 147. Oncology Based Preclinical CRO Distributors
 Table 148. Oncology Based Preclinical CRO Market Trends
 Table 149. Oncology Based Preclinical CRO Market Drivers
 Table 150. Oncology Based Preclinical CRO Market Challenges
 Table 151. Oncology Based Preclinical CRO Market Restraints
 Table 152. Research Programs/Design for This Report
 Table 153. Key Data Information from Secondary Sources
 Table 154. Key Data Information from Primary Sources


List of Figures
 Figure 1. Oncology Based Preclinical CRO Product Picture
 Figure 2. Global Oncology Based Preclinical CRO Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Oncology Based Preclinical CRO Revenue Market Share by Type in 2024 & 2031
 Figure 4. Blood Cancer Product Picture
 Figure 5. Solid Tumors Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Oncology Based Preclinical CRO Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 8. Global Oncology Based Preclinical CRO Revenue Market Share by Application in 2024 & 2031
 Figure 9. In Vitro
 Figure 10. In Vivo
 Figure 11. Oncology Based Preclinical CRO Report Years Considered
 Figure 12. Global Oncology Based Preclinical CRO Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Oncology Based Preclinical CRO Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Oncology Based Preclinical CRO Market Size Market Share by Region: 2024 Versus 2031
 Figure 15. Global Oncology Based Preclinical CRO Revenue Market Share by Region (2020-2031)
 Figure 16. Global Oncology Based Preclinical CRO Revenue Market Share Forecast by Type (2020-2031)
 Figure 17. Global Oncology Based Preclinical CRO Revenue Market Share Forecast by Application (2020-2031)
 Figure 18. Blood Cancer of Oncology Based Preclinical CRO Revenue Market Share by Application, 2024 VS 2031
 Figure 19. Solid Tumors of Oncology Based Preclinical CRO Revenue Market Share by Application, 2024 VS 2031
 Figure 20. Others of Oncology Based Preclinical CRO Revenue Market Share by Application, 2024 VS 2031
 Figure 21. Oncology Based Preclinical CRO Revenue Share by Company (2024)
 Figure 22. Oncology Based Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Blood Cancer Revenue Proportion by Company in 2024
 Figure 24. Solid Tumors Revenue Proportion by Company in 2024
 Figure 25. Others Revenue Proportion by Company in 2024
 Figure 26. North America Oncology Based Preclinical CRO Revenue 2020-2031 (US$ Million)
 Figure 27. North America Oncology Based Preclinical CRO Revenue Market Share by Type (2020-2025)
 Figure 28. North America Oncology Based Preclinical CRO Revenue Market Share by Application (2020-2025)
 Figure 29. Asia-Pacific Oncology Based Preclinical CRO Revenue 2020-2031 (US$ Million)
 Figure 30. Asia-Pacific Oncology Based Preclinical CRO Revenue Market Share by Region (2020-2031)
 Figure 31. Asia-Pacific Oncology Based Preclinical CRO Revenue Market Share by Type (2020-2025)
 Figure 32. Asia-Pacific Oncology Based Preclinical CRO Revenue Market Share by Application (2020-2025)
 Figure 33. Europe Oncology Based Preclinical CRO Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 34. Europe Oncology Based Preclinical CRO Revenue Market Share by Country (2020-2031)
 Figure 35. Europe Oncology Based Preclinical CRO Revenue Market Share by Type (2020-2025)
 Figure 36. Europe Oncology Based Preclinical CRO Revenue Market Share by Application (2020-2025)
 Figure 37. Latin America Oncology Based Preclinical CRO Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Latin America Oncology Based Preclinical CRO Revenue Market Share by Country (2020-2031)
 Figure 39. Latin America Oncology Based Preclinical CRO Revenue Market Share by Type (2020-2025)
 Figure 40. Latin America Oncology Based Preclinical CRO Revenue Market Share by Application (2020-2025)
 Figure 41. Middle East and Africa Oncology Based Preclinical CRO Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Middle East and Africa Oncology Based Preclinical CRO Revenue Market Share by Country (2020-2031)
 Figure 43. Middle East and Africa Oncology Based Preclinical CRO Revenue Market Share by Type (2020-2025)
 Figure 44. Middle East and Africa Oncology Based Preclinical CRO Revenue Market Share by Application (2020-2025)
 Figure 45. Oncology Based Preclinical CRO Supply Chain (Upstream and Downstream Market)
 Figure 46. Global Production Market Share of Oncology Based Preclinical CRO Raw Materials by Region in 2024
 Figure 47. Oncology Based Preclinical CRO Distribution Channels
 Figure 48. Global Oncology Based Preclinical CRO Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 49. Global Oncology Based Preclinical CRO Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 50. Bottom-up and Top-down Approaches for This Report
 Figure 51. Data Triangulation
 Figure 52. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Preclinical Oncology CRO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oncology Based In vitro CRO Market Research Report 2024
Global Oncology Based In vivo CRO Market Research Report 2024
Global Preclinical Contract Research Organization CRO Market Research Report 2025
Global Pharmaceutical Development Preclinical CRO Market Research Report 2025
Clinical CRO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Preclinical CRO Treatment Market Insights Forecast to 2030
Global Pre Clinical CROs Services Market Research Report 2024
Pre Clinical Contract Research Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Contract Research Organisations CROs Market Research Report 2024
Global Full Service CRO Market Research Report 2024
Global Healthcare Contract Research Organization Market Insights Forecast to 2030
Global CRO in Clinical Trials Market Research Report 2024
Global Full Service Clinical Research Organization CRO Market Research Report 2025
Clinical Research Organization Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Clinical Contract Research Organization Services Market Research Report 2024
Global Clinical and Non clinical Contract Research Organization Services Market Research Report 2024
Healthcare Contract Research Organizations CRO Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Contract Research Organization Solution Market Research Report 2025
Contract Research Organizations Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions